BioAge Labs (BIOA) Change in Accured Expenses (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Change in Accured Expenses data on file, last reported at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 44.7% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$306000.0 (down 116.97% YoY), and the FY2025 full-year result was -$3.4 million, down 173.73% from the prior year.
• Change in Accured Expenses eased to -$3.8 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.2 million in Q3 2024 to a low of -$6.9 million in Q1 2025.
• A 4-year average of $38200.0 and a median of $406000.0 in 2025 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 264.55% in 2025, while the deepest fall reached 106.61% in 2025.
• Tracing BIOA's Change in Accured Expenses over 4 years: stood at $3.0 million in 2023, then retreated by 26.59% to $2.2 million in 2024, then plunged by 38.71% to $1.4 million in 2025, then tumbled by 383.83% to -$3.8 million in 2026.
• Business Quant data shows BIOA's Change in Accured Expenses at -$3.8 million in Q1 2026, $1.4 million in Q4 2025, and -$542000.0 in Q3 2025.